Ann: First VivaGel BV launch globally in Australia by Aspen, page-10

So let us agree, Starpharma is no longer a speculative buy stock.. It has a world first product which stands alone as an otc treatment for a condition that 1 in 3 women have suffered for ever.After reading the ANN this morning I went a walk along a quiet beach in Bali to contemplate my journey with SPL over last few years, my wife and I have some1/4 mill shares mostly bought at 66 to 70 cents a fair lump of our retirement dough ( 65 64 now ). We have had our ups and downs with SPL but held on regardless. Now we do not need to make any changes to our investment till march 2021, by then I expect Starpharma will be a few $ in sp probably over $5. The FDA glitch will be fixed iether next month or maybe later on, it will be fixed though sooner or later. Our oncology and other programs will bear fruit soon and the Vivagel roll out and sales increases will just keep going. Nice time to be a holder we are pretty comferatable today on our hols. Cheers Thrasher gltah